• Jean-Pierre Bayley, Leiden University Medical Center, Leiden

• Angelika Schnieke, Lehrstuhl fuer Biotechnologie der Nutztiere, TU Muenchen, Muenchen

• Michael P. Murphy, MRC Mitochondrial Biology Unit, Wellcome Trust/MRC Building, Cambridge

• M. Dolores Barrachina, Depto. de Farmacologia, Universidad de Valencia, Valencia

• Kenneth McCreath
• Junior group leader
• Ext.3319

Kenneth McCreath graduated from the University of Aberdeen, Scotland, with a PhD in Biochemistry in 1993. He carried out postdoctoral research in molecular mycology in the laboratory of Prof. Phillips Robbins at MIT from 1993-1995, before returning to Aberdeen with a Pfizer fellowship to study antifungal drug therapy with Prof. Neil Gow (1995-1998). From 1998-2002 he was employed as a research scientist at PPL Therapeutics Inc., Scotland where he worked on transgenic animal production, and was involved in creating the world’s first gene-targeted large animals. He joined the CNIC in November 2002.